FORTIS NSE filing

Fortis Healthcare Recommends ₹1 Final Dividend; Approves FY26 Audited Results

The RealCase readMedium impact Positive

Fortis Healthcare approved its audited financial results for FY26, reporting total income of ₹917,850 lacs and net profit of ₹106,419 lacs. The board recommended a final dividend of ₹1 per equity share and appointed M/s Jitender, Navneet & Co. as Cost Auditors for FY27.

Why it matters

The announcement includes key financial results and a dividend recommendation, which are material to investors. The appointment of a cost auditor is a routine compliance matter but also contributes to governance.

The market read

The approval of audited financial results, recommendation of a final dividend, and appointment of a cost auditor are positive developments for the company.

Fortis Healthcare Limited announced the outcome of its Board Meeting held on May 22, 2026. The Board approved the standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026, with an unmodified audit opinion from B S R & Co. LLP. The company also recommended a final dividend of ₹1 per equity share for the financial year 2025-26, subject to shareholder approval.

Furthermore, the Board appointed M/s Jitender, Navneet & Co., Cost Accountants, as the Cost Auditor for the Financial Year 2026-27. An approved policy for Corporate Social Responsibility was also noted.

The financial results for the year ended March 31, 2026, show total income of ₹917,850 lacs and a net profit after tax of ₹106,419 lacs. The company's revenue from operations stood at ₹912,784 lacs for the full year.

The Board Meeting commenced at 09:35 Hours IST and concluded at 19:35 Hours IST.

Filing to action

What to do with a filing like this

Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.

View original filing